Order Article Reprints

Agema BC, Koolen SLW, de With M, van Doorn N, Heersche N, Oomen-de Hoop E, Visser S, Aerts JGJV, Bins S, van Schaik RHN, et al. Influence of Genetic Variation in COMT on Cisplatin-Induced Nephrotoxicity in Cancer Patients. Genes. 2020; 11(4):358. https://doi.org/10.3390/genes11040358

Agema, Bram C., Stijn L.W. Koolen, Mirjam de With, Nadia van Doorn, Niels Heersche, Esther Oomen-de Hoop, Sabine Visser, Joachim G.J.V. Aerts, Sander Bins, Ron H.N. van Schaik, and et al. 2020. "Influence of Genetic Variation in COMT on Cisplatin-Induced Nephrotoxicity in Cancer Patients" Genes 11, no. 4: 358. https://doi.org/10.3390/genes11040358

Agema, B. C., Koolen, S. L. W., de With, M., van Doorn, N., Heersche, N., Oomen-de Hoop, E., Visser, S., Aerts, J. G. J. V., Bins, S., van Schaik, R. H. N., & Mathijssen, R. H. J. (2020). Influence of Genetic Variation in COMT on Cisplatin-Induced Nephrotoxicity in Cancer Patients. Genes, 11(4), 358. https://doi.org/10.3390/genes11040358